Want to see HK:2219 full AI Analyst Report?
2219 Stock Chart & Stats
HK$2.61
HK$0.00(0.00%)
At close: 4:00 PM EDT
HK$2.61
HK$0.00(0.00%)
Day’s Range― - ―
52-Week RangeHK$2.20 - HK$3.14
Previous CloseN/A
Volume24.50K
Average Volume (3M)722.53K
Market Cap
HK$1.81B
Enterprise ValueHK$528.25
Total Cash (Recent Filing)HK$1.49B
Total Debt (Recent Filing)HK$237.74M
Price to Earnings (P/E)8.4
Beta0.73
Next Earnings
Aug 28, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield9.39%
Share Statistics
EPS (TTM)0.26
Shares Outstanding701,460,000
10 Day Avg. Volume521,468
30 Day Avg. Volume722,533
Financial Highlights & Ratios
PEG Ratio-1.33
Price to Book (P/B)0.72
Price to Sales (P/S)1.28
P/FCF Ratio15.48
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)0.25
Revenue Forecast (FY)HK$1.47B
Bulls Say, Bears Say
Bulls Say
Solid ProfitabilityHealthy gross, operating, and net margins show that core ophthalmic services remain economically attractive. This profitability provides capacity to fund clinical operations and expansion, although sustaining margins will depend on restoring growth and controlling costs.
Conservative Balance SheetVery low leverage limits interest and refinancing pressure, giving Chaoju financial resilience through changing demand conditions. The substantial equity base also preserves flexibility to maintain hospitals, invest in capacity, and support long-term service development.
Diversified Ophthalmic Service NetworkA multi-site platform spanning surgeries, consultations, diagnostics, and disease treatment can diversify patient demand and increase referral opportunities. A broad service mix also supports recurring outpatient activity alongside higher-value procedure revenue over time.
Bears Say
Revenue ContractionThe reversal from growth to contraction indicates weaker recent patient volumes, pricing, or service mix. If sustained, lower revenue would reduce operating leverage and make it harder to expand the hospital network while preserving profitability.
Margin CompressionProfitability remains positive, but the decline in net margin shows that earnings quality has weakened from earlier periods. Continued cost inflation, lower-value service mix, or competitive pricing could constrain future earnings growth and returns on invested capital.
Weak And Volatile Free Cash FlowSharp free-cash-flow deterioration and low conversion from net income suggest that investment or working-capital needs absorbed more internally generated funds. Persistent weakness could limit shareholder distributions and reduce funding available for hospital expansion.
Chaoju Eye Care Holdings Ltd. News
2219 FAQ
What was Chaoju Eye Care Holdings Ltd.’s price range in the past 12 months?
Chaoju Eye Care Holdings Ltd. lowest stock price was HK$2.20 and its highest was HK$3.14 in the past 12 months.
What is Chaoju Eye Care Holdings Ltd.’s market cap?
Chaoju Eye Care Holdings Ltd.’s market cap is HK$1.81B.
When is Chaoju Eye Care Holdings Ltd.’s upcoming earnings report date?
Chaoju Eye Care Holdings Ltd.’s upcoming earnings report date is Aug 28, 2026 which is in 4 days.
How were Chaoju Eye Care Holdings Ltd.’s earnings last quarter?
Chaoju Eye Care Holdings Ltd. released its earnings results on Mar 31, 2026. The company reported HK$0.11 earnings per share for the quarter, missing the consensus estimate of N/A by N/A.
Is Chaoju Eye Care Holdings Ltd. overvalued?
According to Wall Street analysts Chaoju Eye Care Holdings Ltd.’s price is currently Overvalued.
Does Chaoju Eye Care Holdings Ltd. pay dividends?
Chaoju Eye Care Holdings Ltd. pays a Annually dividend of HK$0.242 which represents an annual dividend yield of 9.39%. See more information on Chaoju Eye Care Holdings Ltd. dividends here
What is Chaoju Eye Care Holdings Ltd.’s EPS estimate?
Chaoju Eye Care Holdings Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Chaoju Eye Care Holdings Ltd. have?
Chaoju Eye Care Holdings Ltd. has 701,460,000 shares outstanding.
What happened to Chaoju Eye Care Holdings Ltd.’s price movement after its last earnings report?
Chaoju Eye Care Holdings Ltd. reported an EPS of HK$0.11 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -0.379%.
Which hedge fund is a major shareholder of Chaoju Eye Care Holdings Ltd.?
Currently, no hedge funds are holding shares in HK:2219
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Chaoju Eye Care Holdings Ltd. Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-8.45%
12-Months-Change
Fundamentals
Return on Equity
9.39%
Trailing 12-Months
Asset Growth
9.69%
Trailing 12-Months
Company Description
Chaoju Eye Care Holdings Ltd.
Chaoju Eye Care Holdings Ltd. (2219) is an ophthalmic medical services provider in China that operates a network of eye hospitals and clinics. The group focuses on delivering eye-care services across areas such as refractive correction, cataract treatment, ophthalmology/optometry-related consultations, and other eye disease diagnosis and treatment, serving patients through in-hospital procedures and outpatient visits.
Technical Analysis
EuroEyes International Eye Clinic Limited
―
C-MER Eye Care Holdings Limited
―
Hospital Corporation of China Ltd
―
Town Health International Medical Group Ltd.
―
Arrail Group Ltd.
―